Tags:BioTechCenterDataHealthTechHomeMedtechResearchScience
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Location: United States, New York, City of New Rochelle
Member count: 11-50
Total raised: $16M
Founded date: 2020

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
13.01.2023Series A$16M-finsmes.co...

Mentions in press and media 4

DateTitleDescriptionCategoryAuthorSource
13.01.2023LinusBio R...LinusBio, a New York-based com...USA-finsmes.co...
07.12.2021Linus Biot...NEW YORK, Dec. 7, 2021 /PRNews...--salamancap...
17.11.2021Mount Sina...NEW YORK, Nov. 17, 2021 /PRNew...--salamancap...
-Linus Biot...“Originating from world’s lead...--fastfounde...